{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:13:55Z","timestamp":1761178435521,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.canrad.2014.04.002","type":"journal-article","created":{"date-parts":[[2014,6,6]],"date-time":"2014-06-06T09:16:08Z","timestamp":1402046168000},"page":"701-708","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cryoth\u00e9rapie de rattrapage apr\u00e8s radioth\u00e9rapie prostatique\u00a0: principes, indications, s\u00e9lection des patients, r\u00e9sultats oncologiques et morbidit\u00e9"],"prefix":"10.1016","volume":"18","author":[{"given":"J.-F.","family":"H\u00e9tet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Colls","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Pocholle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Chauveau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Barr\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Hallouin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2014.04.002_bib0005","doi-asserted-by":"crossref","first-page":"F3","DOI":"10.1016\/j.fpurol.2011.10.001","article-title":"Cryoth\u00e9rapie des tumeurs r\u00e9nales par approche laparoscopique","volume":"22","author":"H\u00e9tet","year":"2012","journal-title":"Prog Urol FMC"},{"key":"10.1016\/j.canrad.2014.04.002_bib0010","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/1097-0142(19930815)72:4<1291::AID-CNCR2820720423>3.0.CO;2-I","article-title":"Transrectal ultrasound-guided percutaneous radical cryosurgical ablation of the prostate","volume":"72","author":"Onik","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2014.04.002_bib0015","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1464-410X.2006.06073.x","article-title":"Third-generation cryotherapy for prostate cancer in the UK: a prospective study of the early outcomes in primary and recurrent disease","volume":"97","author":"Cresswell","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.canrad.2014.04.002_bib0020","first-page":"S24","article-title":"Salvage cryosurgery-How I do it","volume":"4","author":"Donnelly","year":"2002","journal-title":"Rev Urol"},{"key":"10.1016\/j.canrad.2014.04.002_bib0025","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000332220","article-title":"Third-generation salvage cryotherapy for radiorecurrent prostate cancer: a centre's experience","volume":"88","author":"Philippou","year":"2012","journal-title":"Urol Int"},{"key":"10.1016\/j.canrad.2014.04.002_bib0030","first-page":"S18","article-title":"Selection of salvage cryotherapy patients","volume":"4","author":"Katz","year":"2002","journal-title":"Rev Urol"},{"key":"10.1016\/j.canrad.2014.04.002_bib0035","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ucl.2009.11.007","article-title":"Primary and salvage cryotherapy for prostate cancer","volume":"37","author":"Finley","year":"2010","journal-title":"Urol Clin N Am"},{"key":"10.1016\/j.canrad.2014.04.002_bib0040","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.canrad.2010.07.222","article-title":"Traitements de rattrapage apr\u00e8s radioth\u00e9rapie prostatique","volume":"14","author":"Baumert","year":"2010","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2014.04.002_bib0045","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s11934-011-0182-4","article-title":"Salvage cryotherapy for radiation-recurrent prostate cancer: outcomes and complications","volume":"12","author":"Finley","year":"2011","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.canrad.2014.04.002_bib0050","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1464-410X.2007.07045.x","article-title":"Salvage cryotherapy for recurrent prostate cancer after radiation failure: a prospective case series of the first 100\u00a0patients","volume":"100","author":"Ismail","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.canrad.2014.04.002_bib0055","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0022-5347(17)38746-3","article-title":"Identification of residual cancer in the prostate following radiation therapy: role of transrectal ultrasound guided biopsy and prostate specific antigen","volume":"142","author":"Kabalin","year":"1989","journal-title":"J Urol"},{"key":"10.1016\/j.canrad.2014.04.002_bib0060","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0360-3016(94)90008-6","article-title":"Proliferative cell nuclear antigen in postradiotherapy prostate biopsies","volume":"30","author":"Crook","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.04.002_bib0065","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1002\/1097-0142(19950501)75:9<2373::AID-CNCR2820750930>3.0.CO;2-2","article-title":"Potential benefit of improved local tumor control in patients with prostate carcinoma","volume":"75","author":"Kuban","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2014.04.002_bib0070","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1200\/JCO.1999.17.4.1155","article-title":"Consensus statements on radiation therapy of prostate cancer: guidelines for prostate re-biopsy after radiation and for radiation therapy with rising PSA levels after radical prostatectomy. ASTRO consensus panel","volume":"17","author":"Cox","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2014.04.002_bib0075","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ijrobp.2009.04.090","article-title":"Detection of local, regional, and distant recurrence in patients with PSA relapse after external-beam radiotherapy using (11C)-choline positron emission tomography","volume":"77","author":"Breeuwsma","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.04.002_bib0080","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.juro.2007.05.137","article-title":"Salvage cryoablation of the prostate: follow-up and analysis of predictive factors for outcome","volume":"178","author":"Ng","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.canrad.2014.04.002_bib0085","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.urology.2008.03.040","article-title":"Partial salvage cryoablation of the prostate for recurrent prostate cancer after radiotherapy failure","volume":"72","author":"Eisenberg","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.canrad.2014.04.002_bib0090","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.juro.2008.04.005","article-title":"Salvage prostate cryoablation: initial results from the Cryo On-Line Data registry","volume":"180","author":"Pisters","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.canrad.2014.04.002_bib0095","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1464-410X.2009.09078.x","article-title":"A pretreatment nomogram predicting biochemical failure after salvage cryotherapy for locally recurrent prostate cancer","volume":"106","author":"Spiess","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.canrad.2014.04.002_bib0100","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.eururo.2010.12.012","article-title":"Disease-free survival following salvage cryotherapy for biopsy-proven radio-recurrent prostate cancer","volume":"60","author":"Williams","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.canrad.2014.04.002_bib0105","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1464-410X.2011.10659.x","article-title":"Achieving the \u201cbifecta\u201d using salvage cryotherapy for locally recurrent prostate cancer: analysis of the Cryo On-Line Data (COLD) registry data","volume":"110","author":"Spiess","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.canrad.2014.04.002_bib0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eururo.2012.07.008","article-title":"Salvage cryosurgery of the prostate for failure after primary radiotherapy or cryosurgery: long-term clinical, functional, and oncologic outcomes in a large cohort at a tertiary referral centre","volume":"64","author":"Wenske","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.canrad.2014.04.002_bib0115","doi-asserted-by":"crossref","first-page":"E256","DOI":"10.1111\/j.1464-410X.2012.11695.x","article-title":"Predictors of biochemical failure in patients undergoing prostate whole-gland salvage cryotherapy: a novel risk stratification model","volume":"112","author":"Spiess","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.canrad.2014.04.002_bib0120","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/bju.12151","article-title":"Salvage focal and salvage total cryoablation for locally recurrent prostate cancer after primary radiation therapy","volume":"112","author":"de Castro Abreu","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.canrad.2014.04.002_bib0125","doi-asserted-by":"crossref","first-page":"F111","DOI":"10.1016\/j.fpurol.2013.06.003","article-title":"Cryoth\u00e9rapie focale pour cancer localis\u00e9 de la prostate\u00a0: principes, indications, r\u00e9sultats","volume":"23","author":"H\u00e9tet","year":"2013","journal-title":"Prog Urol FMC"},{"key":"10.1016\/j.canrad.2014.04.002_bib0130","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.eururo.2012.02.051","article-title":"Salvage cryoablation for locally recurrent prostate cancer following primary radiotherapy","volume":"61","author":"Mouraviev","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.canrad.2014.04.002_bib0135","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.1464-410X.2006.06347.x","article-title":"Histological changes in prostate biopsies after salvage cryotherapy: effect of chronology and the method of biopsy","volume":"98","author":"Izawa","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.canrad.2014.04.002_bib0140","doi-asserted-by":"crossref","first-page":"E125","DOI":"10.5489\/cuaj.748","article-title":"The pattern of prostate cancer local recurrence after radiation and salvage cryoablation","volume":"5","author":"Ng","year":"2011","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.canrad.2014.04.002_bib0145","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/S0022-5347(05)66246-5","article-title":"Results of salvage cryoablation of the prostate after radiation: identifying predictors of treatment failure and complications","volume":"165","author":"Chin","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.canrad.2014.04.002_bib0150","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s00345-012-0982-2","article-title":"Outcomes of salvage prostate cryotherapy stratified by pre-treatment PSA: update from the COLD registry","volume":"31","author":"Spiess","year":"2013","journal-title":"World J Urol"},{"key":"10.1016\/j.canrad.2014.04.002_bib0155","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1200\/JCO.2002.06.086","article-title":"Salvage cryotherapy for recurrent prostate cancer after radiotherapy: variables affecting patient outcome","volume":"20","author":"Izawa","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2014.04.002_bib0160","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/j.1464-410X.2010.09297.x","article-title":"Prognostic value of initial prostate-specific antigen levels after salvage cryoablation for prostate cancer","volume":"106","author":"Levy","year":"2010","journal-title":"BJU Int"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321814000687?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321814000687?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:22:26Z","timestamp":1761135746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321814000687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S1278321814000687"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2014.04.002","relation":{},"ISSN":["1278-3218"],"issn-type":[{"type":"print","value":"1278-3218"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cryoth\u00e9rapie de rattrapage apr\u00e8s radioth\u00e9rapie prostatique\u00a0: principes, indications, s\u00e9lection des patients, r\u00e9sultats oncologiques et morbidit\u00e9","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2014.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2014.05.005","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2014.05.006","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}